Growth Metrics

Insulet (PODD) Net Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.11%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4,440.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 156.62%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 156.62%
Dec 31, 2025 0.99%
Sep 30, 2025 13.03%
Jun 30, 2025 -88.07%
Mar 31, 2025 -31.07%
Dec 31, 2024 -2.61%
Sep 30, 2024 49.33%
Jun 30, 2024 590.84%
Mar 31, 2024 116.39%
Dec 31, 2023 508.24%
Sep 30, 2023 1,098.08%
Jun 30, 2023 178.00%
Mar 31, 2023 -14.39%
Dec 31, 2022 -41.78%
Sep 30, 2022 -141.27%
Jun 30, 2022 -40.00%
Dec 31, 2021 270.76%
Sep 30, 2021 8.62%
Jun 30, 2021 -273.61%
Dec 31, 2020 -442.00%
Sep 30, 2020 1,350.00%
Jun 30, 2020 928.57%
Mar 31, 2020 -147.73%
Dec 31, 2019 -49.50%
Sep 30, 2019 -51.78%
Jun 30, 2019 182.79%
Mar 31, 2019 167.32%
Dec 31, 2016 100.30%
Sep 30, 2016 93.21%
Jun 30, 2016 -91.66%
Mar 31, 2016 -28.74%
Dec 31, 2015 -520.54%
Sep 30, 2015 91.30%
Jun 30, 2015 106.30%
Mar 31, 2015 77.34%
Dec 31, 2014 26.40%
Sep 30, 2014 49.06%
Jun 30, 2014 -176.75%
Mar 31, 2014 42.39%
Dec 31, 2013 75.48%
Sep 30, 2013 -71.46%
Jun 30, 2013 27.33%
Mar 31, 2013 27.84%
Dec 31, 2012 28.91%
Sep 30, 2012 8.44%
Jun 30, 2012 -79.07%
Mar 31, 2012 -50.08%
Dec 31, 2011 31.25%
Sep 30, 2011 -12.08%
Jun 30, 2011 41.04%